Home > Insider Trading > Filing (0000950138-15-000157)

Filing Details

Accession Number:: 0000950138-15-000157
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2015-02-26 16:03:22
Reporting Period:: 2015-02-24

Filing Date:: 2015-02-26
Accepted Time:: 2015-02-26 16:03:22
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1532063	Express Scripts Holding Co.	ESRX	Retail-Drug Stores And Proprietary Stores (5912)	452884094

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1506111	D. Glen Stettin	C/O Express Scripts Holding Company One Express Way St. Louis MO 63121	Sr. Vp, Clin. Res. & New Sol.	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Disposition	2015-02-24	3,028	$87.62	16,829	No	4	F	Direct
Common Stock	Acquisiton	2015-02-24	21,739	$47.61	38,568	No	4	M	Direct
Common Stock	Disposition	2015-02-24	4,200	$86.68	34,368	No	4	S	Direct
Common Stock	Disposition	2015-02-24	11,039	$87.55	23,329	No	4	S	Direct
Common Stock	Disposition	2015-02-24	6,500	$88.35	16,829	No	4	S	Direct
Common Stock	Disposition	2015-02-25	5,864	$87.31	10,965	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	F	Direct
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Express Scripts Holding Company Common Stock	Non-Qualified Stock Option (Right-to-Buy)	Disposition	2015-02-24	21,739	$0.00	21,739	$47.61

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0			No	4	M	Direct

Footnotes

Represents shares tendered to Company to cover Reporting Person's tax liability due upon vesting of restricted stock units previously awarded under long-term incentive plans.
The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $86.11 to $87.05, inclusive. The Reporting Person undertakes to provide to Express Scripts Holding Company, any security holder of Express Scripts Holding Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.
The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $87.14 to $88.11, inclusive. The Reporting Person undertakes to provide to Express Scripts Holding Company, any security holder of Express Scripts Holding Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.
The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $88.14 to $88.78, inclusive. The Reporting Person undertakes to provide to Express Scripts Holding Company, any security holder of Express Scripts Holding Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.
The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
Grant of stock options pursuant to the Medco Health Solutions, Inc. Amended and Restated Stock Incentive Plan. Vested in three (3) equal installments on February 24, 2013, February 24, 2014, and February 24, 2015.